Abstract:Most occurrences of large patent ductus arteriosus (PDAs) of ≥10 mm have been surgically closed, and transcatheter closure of these large PDAs was only reported in a few case reports. The present study reviewed our experience in transcatheter closure of such large PDAs with a Chinese self-expandable occluder, which is similar to but much cheaper than the Amplatzer occluder. From July 2000 to January 2008, 23 patients underwent transcatheter closure of large PDA ≥10 mm with this kind of occluder. The mean (SD) age of the patients was 38.0 (15.6) years (range 18–75 years). Radiographs of the chest, electrocardiograms, and echocardiograms were used for follow-up evaluation of the treatment within 1 day, 1 month, 6 months, and then every year after successful closure. The mean (SD) angiographic PDA diameter was 12.8 (2.6) mm (range 10–18 mm) and the mean occluder diameter was 18.0 (2.9) mm (range 16–22 mm). The occluders were delivered successfully and closed the PDA completely in 19 out of the 23 patients. Pulmonary arterial pressures decreased significantly after occlusion in patients with successful treatment: 67.3 (24.7) mmHg (range 29–122 mmHg) before occlusion and 42.3 (22.0) mmHg (range 19–98 mmHg) immediately after the procedure. Radiographs of the chest and echocardiograms showed that the diameters of the left atrium, left ventricle, and the main pulmonary artery decreased, and the ejection fraction (EF) increased at a mean (SD) follow-up of 36.3 (18.7) months (range 6–72 months). No severe complication occurred. The immediate and long-term outcomes suggested that transcatheter closure of PDAs with the native PDA occluder is a safe and effective treatment for adults with large PDA ≥10 mm.

A Safe Technique for Closure of Patent Ductus Arteriosus in Adult Patients

Patent Ductus Arteriosus Closure Using the New Amplatzer Duct Occluder. Preliminary Results and Review of the Literature.

[Transcatheter Closure for Patent Ductus Arteriosus in Children].

Clinical Efficacy of Transcatheter Induced Closure in Patients With Small Patent Ductus Arteriosus

Transcatheter Closure of Patent Ductus Arteriosus with Special Conformation

Safety and Efficacy of Transcatheter Closure of Patent Ductus Arteriosus with Severe Mitral Regurgitation in Adults.

Transcatheter Closure of Adult Patent Ductus Arteriosus with Severe Pulmonary Hypertension

Echocardiography-guided percutaneous closure of patent ductus arteriosus without arterial access: Feasibility and safety for a new strategy

Closure of Patent Ductus Arteriosus with or Without Beating Heart under Cardiopulmonary Bypass

Application of Da Vinci robot assisted endoscopic technique in the treatment of patent ductus arteriosus in children

PERCUTANEOUS TRANSCATHETER CLOSURE OF PATENT DUCTUS ARTERIOSUS WITH AN AMPLATZER DUCT OCCLUDER USING RETROGRADE GUIDEWIRE‐ESTABLISHED FEMORAL ARTERIOVENOUS LOOP

Transcatheter Closure of Patent Ductus Arteriosus Using Amplatzer Occluder Device

Transcatheter Closure of Special Patent Ductus Arteriosus

Safety and efficacy of transcatheter closure of large patent ductus arteriosus in adults with a self-expandable occluder

Transcatheter Closure of Patent Ductus Arteriosus Using New Amplatzer Duct Occluder

Clinical curative effect of domestic occluder in treatment of patent ductus arteriosus

Feasibility and safety of transcatheter intervention for complex patent ductus arteriosus.

Transcatheter closure of giant patent ductus arteriosus by using domestic occluder

Application for transcatheter closure of patent ductus arteriosus by amplatzer duct occluder Ⅱ

Transcatheter closure of patent ductus arteriosus with ≥ 8 mm diameter using th e Amplatzer duct occluder

Clinical follow-up of transcatheter closure of large patent ductus arteriosus using domestic occluders in children